Neuphoria Therapeutics (NEUP) Goodwill (2020 - 2025)
Historic Goodwill for Neuphoria Therapeutics (NEUP) over the last 6 years, with Q4 2025 value amounting to $8.7 million.
- Neuphoria Therapeutics' Goodwill rose 393.33% to $8.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.7 million, marking a year-over-year increase of 393.33%. This contributed to the annual value of $8.6 million for FY2025, which is N/A changed from last year.
- Per Neuphoria Therapeutics' latest filing, its Goodwill stood at $8.7 million for Q4 2025, which was up 393.33% from $8.7 million recorded in Q3 2025.
- Neuphoria Therapeutics' 5-year Goodwill high stood at $9.2 million for Q2 2022, and its period low was $8.4 million during Q4 2024.
- Moreover, its 5-year median value for Goodwill was $8.7 million (2025), whereas its average is $8.8 million.
- As far as peak fluctuations go, Neuphoria Therapeutics' Goodwill tumbled by 512.09% in 2023, and later soared by 393.33% in 2025.
- Quarter analysis of 5 years shows Neuphoria Therapeutics' Goodwill stood at $9.2 million in 2021, then grew by 0.66% to $9.2 million in 2022, then dropped by 5.12% to $8.7 million in 2023, then decreased by 3.86% to $8.4 million in 2024, then increased by 3.93% to $8.7 million in 2025.
- Its Goodwill stands at $8.7 million for Q4 2025, versus $8.7 million for Q3 2025 and $8.6 million for Q2 2025.